US4743542A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for forestalling the hook effect in a multi-ligand immunoassay system
Assignee: Ortho Clinical Diagnostics Inc
•
Filing: 1985-04-11
•
Granted: 1988-05-10
•
Expires: 2005-04-11
Abstract
Abstract A method is provided for substantially increasing the dynamic range of an immunoassay and forestalling the hook effect observed with very large ligand concentrations in aqueous samples. The method comprises the addition of ligand binding partners which do not have labels associated therewith to compete with labeled ligand binding partners thereby effectively eliminating the presence of the excess ligand in the sample solution. The conversant method for ligand binding partner immunoassays is also provided.
Inventors
- 👤 Henry A. Graham, Jr.
- 👤 Peter Lisi
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 18:43
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54393; Y; Y10; Y10S; Y10S435/00; Y10S435/962; Y10S435/968; Y10S436/00; Y10S436/815; Y10S436/817; Y10S436/818
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
159 words
In an immunoassay for the detection of a ligand wherein a first ligand binding partner specific for the ligand to be detected is immobilized by attachment to an insoluble surface and is reacted with a second ligand binding partner specific for the ligand to be detected, said second ligand binding partner having a detectable label and forming a sandwich complex with said first binding partner in accordance with the presence or absence of the ligand to be detected, the improvement comprising: (a) providing a haptenated first ligand binding partner and an insoluble isotactic surface means capable of reacting with and immobilizing said haptenated first binding partner; and (b) adding to said reactants either additional non-haptenated first ligand binding partner or non-labeled second ligand binding partner or a combination thereof, so as to bind excess ligand to be detected and permit formation of an increased number of sandwich complexes thereby increasing the dynamic range of detection sensitivity to said immunoassay.
Claim 2
Dependent Claim
159 words
In an immunoassay for the detection of a ligand wherein a first ligand binding partner specific for the ligand to be detected is immobilized by attachment to an insoluble surface and is reacted with a second ligand binding partner specific for the ligand to be detected, said second ligand binding partner having a detectable label and forming a sandwich complex with said first binding partner in accordance with the presence or absence of the ligand to be detected, the improvement comprising: (a) providing a haptenated first ligand binding partner and an insoluble isotactic surface means capable of reacting with and immobilizing said haptenated first binding partner; and (b) adding to said reactants either additional non-haptenated first ligand binding partner or non-labeled second ligand binding partner or a combination thereof, so as to bind excess ligand to be detected and permit formation of an increased number of sandwich complexes thereby increasing the dynamic range of detection sensitivity to said immunoassay.
Claim 3
Dependent Claim
17 words
The immunoassay of claim 1, wherein the first ligand binding partner is haptenated with a fluorescent molecule.
Claim 4
Dependent Claim
19 words
The immunoassay of claim 1, wherein the isotactic surface means is a latex bead coated with anti-hapten monoclonal antibody.
Claim 5
Dependent Claim
134 words
In an immunoassay for the detection of a ligand wherein a first ligand binding partner associated with an insoluble surface and specific for the ligand to be detected is reacted with a second ligand binding partner specific for the ligand to be detected, said second ligand binding partner having a detectable label and forming a sandwich complex with said first binding partner in accordance with the presence or absence of the ligand to be detected, the improvement comprising: adding to said reactants either additional first ligand binding partner not associated with said insoluble surface or non-labeled second ligand binding partner or a combination thereof, so as to bind excess ligand to be detected and permit formation of an increased number of sandwich complexes thereby increasing the dynamic range of detection sensitivity of said immunoassay.
Claim 6
Dependent Claim
134 words
In an immunoassay for the detection of a ligand wherein a first ligand binding partner associated with an insoluble surface and specific for the ligand to be detected is reacted with a second ligand binding partner specific for the ligand to be detected, said second ligand binding partner having a detectable label and forming a sandwich complex with said first binding partner in accordance with the presence or absence of the ligand to be detected, the improvement comprising: adding to said reactants either additional first ligand binding partner not associated with said insoluble surface or non-labeled second ligand binding partner or a combination thereof, so as to bind excess ligand to be detected and permit formation of an increased number of sandwich complexes thereby increasing the dynamic range of detection sensitivity of said immunoassay.
Claim 7
Dependent Claim
14 words
The immunoassay of claim 1 or claim 4, wherein the ligand is an antigen.
Claim 8
Dependent Claim
18 words
The immunoassay of claim 1 or claim 4, wherein the first ligand binding partner is a monoclonal antibody.
Claim 9
Dependent Claim
18 words
The immunoassay of claim 1 or claim 4, wherein the second ligand binding partner is a monoclonal antibody.
Claim 10
Dependent Claim
18 words
The immunoassay of claim 1 or claim 4, wherein the detectable label is a fluorescent or enzyme label.
Claim 11
Dependent Claim
23 words
The immunoassay of claim 1 or claim 4, wherein the dynamic range of detection sensitivity is increased by a factor of about 2.5.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-05-10 | 1991-11-09 | 1992-05-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-05-10 | 1995-11-09 | 1996-05-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-05-10 | 1999-11-09 | 2000-05-10 | $7700.00 | Window Closed / Lapsed |